An $80-100 million Australian facility in Brisbane, set to open in early 2026.
Designed as the nation’s first scale-up biomedical manufacturing hub for biotech startups to develop drugs, vaccines, and medical devices for clinical trials, fostering local innovation and creating skilled jobs.
